November 4, 2025 Q3 2025 Group Highlights Comparable order intake growth 8% Group sales amounted to EUR 4.3 billion, reflecting 3% increase in comparable sales Income from operations was EUR 330 million Adjusted EBITA margin increased by 50 basis points to 12.3% of sales Operating cash flow of EUR 327 million, with a free cash [...]
Sunrise, Florida, Nov. 03, 2025 (Korea Bizwire) – MedPro International, a leading provider of workforce solutions connecting foreign-educated healthcare professionals with U.S. healthcare organizations, has been officially recertified by the Alliance for Ethical International Recruitment Practices as an Alliance Certified Ethical Recruiter. This certification, valid through September 30, 2028, reaffirms MedPro International’s commitment to fair, transparent, [...]
This football season, Teva is increasing education around tardive dyskinesia (TD) by launching ‘The Other TD’ campaign TD is a chronic movement disorder impacting one in four people who take certain prescription mental health medications. While TD can impact your daily life, it can be treated without interrupting your mental health treatment1-4 Younger individuals, men, and [...]
TEL AVIV, Israel, Oct. 31, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, will present at two upcoming investor conferences in November as follows: UBS Global Healthcare Conference Monday, November 10, 2025, at 8:45 A.M. Eastern Time (ET) Jefferies London Healthcare Conference Tuesday, [...]
GENEVA, Oct. 30, 2025 (Korea Bizwire) – The WHO’s upcoming COP11 meeting in Geneva is sparking fierce debate, as activists from the World Vapers’ Alliance project a clear message onto the venue: consumers must be recognised, not sidelined. Michael Landl, WVA Director, called the conference an echo chamber stuck in outdated, anti-science thinking that fails [...]
ADELAIDE, Australia, Oct. 30, 2025 (Korea Bizwire) – Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence. The center is built to speed up clinical development by including therapeutic leaders early in design, bolstering patient recruitment and retention, and guiding studies from [...]
October 30, 2025 10-year collaboration aims to connect scalable monitoring technology that streamlines workflows, supporting patient safety and the patient and clinician experience Amsterdam, the Netherlands and Newport Beach, Calif., USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Hoag, Orange County, California’s highest-ranked hospital, today announced a landmark 10-year strategic collaboration. The [...]
The licensed small molecule program aims to address significant unmet needs for autoimmune diseases. Program adds to Boehringer’s pipeline and its commitment to deliver breakthrough therapies for patients with inflammatory diseases. Ingelheim, Germany, and Tokyo, Japan, [October 30, 2025] – Boehringer Ingelheim and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:4151, President and COO: Abdul Mullick) today announced that Boehringer Ingelheim has licensed a pre-clinical program from Kyowa Kirin to develop [...]
CALGARY, Alberta, Oct. 29, 2025 (Korea Bizwire) – Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in cardiovascular imaging solutions, today announced that its cvi42 | Plaque solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for clinical use in the United States. This innovative, AI-enabled [...]
Decision Immediately Expands Access to Heart Failure Therapy with National Coverage for More Than 66 Million[1] Patients MARLTON, N.J., Oct. 29, 2025 (Korea Bizwire) – Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today that the Centers for Medicare and Medicaid Services (CMS) issued [...]